Literature DB >> 21145387

Depletion of glutathione does not affect electron transport chain complex activity in brain mitochondria: Implications for Parkinson disease and postmortem studies.

Simon J R Heales1, Adrian Menzes, Gavin P Davey.   

Abstract

Glutathione is an important antioxidant in the brain that appears to be decreased, in conjunction with mitochondrial complex I activity, in Parkinson disease patients. In postmortem analysis, measurement of glutathione levels and complex I activity can be delayed up to 20h. We investigated whether depletion of glutathione in the preweanling rat induces a reduction in complex I activity in brain mitochondria and the effects that postmortem delay has on glutathione levels and electron transport chain activity. After injection with the glutamate-cysteine ligase inhibitor, buthionine sulfoximine (L-BSO), glutathione levels were decreased by 53% compared to the control values in whole-brain homogenates. During postmortem delay of 24h, in which animals were kept at 4°C, the levels of glutathione decreased in the control group by 58% and in the L-BSO-treated group by 79%. However, during this period, there were no changes in mitochondrial electron transport chain complex I, II-III, or IV activity in either group. These results suggest that a preexisting deficiency of glutathione or a loss of glutathione during postmortem delay does not influence mitochondrial respiratory chain activity in the brain.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145387     DOI: 10.1016/j.freeradbiomed.2010.11.032

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster.

Authors:  M J Manjunath
Journal:  J Food Sci Technol       Date:  2013-12-01       Impact factor: 2.701

2.  An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII.

Authors:  Paul S Donnelly; Jeffrey R Liddell; SinChun Lim; Brett M Paterson; Michael A Cater; Maria S Savva; Alexandra I Mot; Janine L James; Ian A Trounce; Anthony R White; Peter J Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

3.  Glutathione deficiency in Gclm null mice results in complex I inhibition and dopamine depletion following paraquat administration.

Authors:  Li-Ping Liang; Terrance J Kavanagh; Manisha Patel
Journal:  Toxicol Sci       Date:  2013-05-23       Impact factor: 4.849

4.  X-ray absorption spectroscopy at the sulfur K-edge: a new tool to investigate the biochemical mechanisms of neurodegeneration.

Authors:  Mark J Hackett; Shari E Smith; Phyllis G Paterson; Helen Nichol; Ingrid J Pickering; Graham N George
Journal:  ACS Chem Neurosci       Date:  2012-01-02       Impact factor: 4.418

5.  The promise of neuroprotective agents in Parkinson's disease.

Authors:  Stacey E Seidl; Judith A Potashkin
Journal:  Front Neurol       Date:  2011-11-21       Impact factor: 4.003

6.  Fatty acid nitroalkenes induce resistance to ischemic cardiac injury by modulating mitochondrial respiration at complex II.

Authors:  Jeffrey R Koenitzer; Gustavo Bonacci; Steven R Woodcock; Chen-Shan Chen; Nadiezhda Cantu-Medellin; Eric E Kelley; Francisco J Schopfer
Journal:  Redox Biol       Date:  2015-11-17       Impact factor: 11.799

7.  Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson's disease.

Authors:  Sandrine C Foti; Iain Hargreaves; Stephanie Carrington; Aoife P Kiely; Henry Houlden; Janice L Holton
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

Review 8.  Investigating mitochondrial redox state using NADH and NADPH autofluorescence.

Authors:  Thomas S Blacker; Michael R Duchen
Journal:  Free Radic Biol Med       Date:  2016-08-09       Impact factor: 7.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.